Urology · Neptune, NJ
NPI
1366425332
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1944 Corlies Ave, Suite 101
Neptune, NJ, 07753
Phone (732) 840-6606
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
24,196 services
Medicare patients, 2024
1,224
Average age 76
Drug cost, 2024
$274K
5,082 prescriptions
Company payments, 2025
$400
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew S Tobin was code 87798 (infectious agent detection by dna/rna), 6,344 times for 251 patients. In total Matthew S Tobin billed 24,196 services in 77 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87798 Infectious Agent Detection by DNA/RNA | Office | 6,344 | 251 | $34.39 | $218K |
| 87150 Infectious Agent Detection by DNA/RNA | Office | 5,988 | 255 | $34.39 | $206K |
| 99214 Office E&M - Established | Office | 2,106 | 964 | $106.35 | $224K |
| 81003 Clinical Chemistry | Office | 2,055 | 997 | $2.19 | $4,505 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 996 | 256 | $34.39 | $34K |
| 51798 Ultrasound - Nonspecific | Office | 900 | 548 | $9.69 | $8,721 |
| 99443 Telephone Services | Office | 704 | 413 | $89.19 | $63K |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 498 | 256 | $68.80 | $34K |
| 87500 Infectious Agent Detection by DNA/RNA | Office | 498 | 256 | $34.39 | $17K |
| 87641 Infectious Agent Detection by DNA/RNA | Office | 498 | 256 | $34.39 | $17K |
| 87640 Infectious Agent Detection by DNA/RNA | Office | 498 | 256 | $34.39 | $17K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 372 | 41 | $139.23 | $52K |
| 96402 Chemotherapy Administration | Office | 342 | 41 | $30.75 | $11K |
| 99213 Office E&M - Established | Office | 331 | 170 | $78.41 | $26K |
| 51741 Test - Miscellaneous | Office | 169 | 127 | $9.75 | $1,648 |
By year: 2022 $780K for 12,331 services; 2023 $842K for 15,998 services; 2024 $1.2M for 24,196 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 6,344 | 251 | $34.39 | $218K |
| 87150 Infectious Agent Detection by DNA/RNA | 5,988 | 255 | $34.39 | $206K |
| 81003 Clinical Chemistry | 2,055 | 997 | $2.19 | $4,505 |
| 87481 Infectious Agent Detection by DNA/RNA | 996 | 256 | $34.39 | $34K |
| 87801 Infectious Agent Detection by DNA/RNA | 498 | 256 | $68.80 | $34K |
| 87500 Infectious Agent Detection by DNA/RNA | 498 | 256 | $34.39 | $17K |
| 87640 Infectious Agent Detection by DNA/RNA | 498 | 256 | $34.39 | $17K |
| 87641 Infectious Agent Detection by DNA/RNA | 498 | 256 | $34.39 | $17K |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew S Tobin prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,454 prescriptions and refills. In total Matthew S Tobin wrote 5,082 Medicare prescriptions that cost $274K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,454 | 4,173 | 459 | $26K |
| Finasteride Generic | 1,318 | 3,824 | 401 | $21K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 526 | 1,518 | 152 | $14K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 275 | 275 | 204 | $1,565 |
| Ciprofloxacin Hcl Generic | 182 | 182 | 142 | $568 |
| Dutasteride Generic | 172 | 504 | 49 | $7,063 |
| Myrbetriq Mirabegron | 130 | 259 | 38 | $111K |
| Silodosin Generic | 101 | 296 | 26 | $11K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 100 | 100 | 75 | $179 |
| Doxazosin Mesylate Generic | 84 | 225 | 29 | $1,351 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 75 | 184 | 27 | $2,509 |
| Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl | 68 | 196 | 21 | $19K |
| Amoxicillin Generic | 53 | 53 | 35 | $47.22 |
| Cefuroxime Cefuroxime Axetil | 52 | 52 | 43 | $361 |
| Phenazopyridine Hcl Generic | 48 | 50 | 32 | $216 |
Brand drugs: 263 claims; generic drugs: 4,766 claims; opioid claims: 78.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew S Tobin $400 ($400 in general payments such as food, travel and fees) from 7 companies. The largest payer was Calyxo, Inc. with $204.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.